Recombinant Human HTRA4 Protein，His

HTRA4, a member of the high-temperature requirement A (HTRA) serine protease family, has garnered significant attention in recent years due to its multifaceted roles in various biological processes and its potential implications in human diseases. Initially characterized for its involvement in extracellular matrix remodeling and proteolytic activity, HTRA4 has emerged as a critical player in both normal physiological functions and pathological conditions, including cancer and cardiovascular diseases. Research has shown that HTRA4 regulates key signaling pathways and influences cellular processes such as apoptosis, proliferation, and inflammation. Furthermore, atypical expression levels of HTRA4 have been implicated in tumor progression and metastasis, making it a potential biomarker for cancer diagnostics and a target for therapeutic intervention. The recombinant expression of HTRA4 provides a valuable tool for elucidating its specific functions and mechanisms of action. As the understanding of HTRA4's role in health and disease continues to deepen, the development of recombinant HTRA4 protein is essential for conducting detailed studies, including its interactions with substrates and inhibitors. This research could pave the way for novel therapeutic strategies aimed at modulating HTRA4 activity in various pathological contexts, ultimately contributing to improved disease management and patient outcomes.